NIH-funded research R01 grant

Improving warfarin dosing using machine learning algorithms

Official title: Pharmacogenetic Refinement of the Warfarin Dose Using Machine Learning

Funded at Washington University · NIH-10862482 · Data updated 2026-11-12

This study is looking to make taking warfarin, a medicine that helps prevent blood clots, safer and more effective by creating smarter dosing tools that use your health and genetic information, so doctors can give you the best dose right from your medical records.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startJuly 15, 2024
Project endJune 30, 2028
Funding year2024
Award (this year)$399,423
NIH project number1R01HL173734-01
Project IDNIH-10862482 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who are starting warfarin therapy for conditions requiring anticoagulation.

Less likely to help

Patients who are not candidates for warfarin therapy or those who have contraindications to anticoagulation may not benefit from this research.

What this research studies

This research focuses on enhancing the safety and effectiveness of warfarin, a medication used to prevent blood clots. By developing advanced dosing algorithms that incorporate clinical and genetic information, the study aims to provide more accurate dosing recommendations for patients starting warfarin therapy. The algorithms will be integrated into electronic health records at multiple medical centers, allowing healthcare providers to access real-time decision support. This approach seeks to minimize the risks of overdose and bleeding associated with warfarin use.

Why it matters

Potential benefit: If successful, this research could lead to safer and more effective warfarin dosing, reducing the risk of complications for patients.

How similar studies have gone: Previous research has shown success in using algorithm-based approaches for medication dosing, indicating a promising avenue for this study.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Gage, Brian F — Washington University
  • Study coordinator: Gage, Brian F

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.